Live feed
·
INSIDERFilingvia Quantisnow
Seres Therapeutics Inc. logo

Officer Henn Matthew R converted options into 238 shares and sold $580 worth of shares (77 units at $7.53) as part of a pre-agreed trading plan, increasing direct ownership by 2% to 7,838 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
Stocks in this Quantisnow insight
Quantisnow market dataNASDAQ
Seres Therapeutics Inc. logo
MCRB
Seres Therapeutics Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Listed since
2015
Follow MCRBFull MCRB profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MCRB (Seres Therapeutics Inc.) and more on Quantisnow.